Literature DB >> 12542843

Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.

Falko Schmeisser1, Megan Donohue, Jerry P Weir.   

Abstract

Although herpes simplex virus (HSV) vectors appear to have great potential as gene delivery vectors both in vitro and in vivo, the expression of foreign genes in such vectors cannot be easily regulated. Of the known eukaryotic regulatory systems, the tetracycline-inducible gene expression system is perhaps the most widely used because of its induction characteristics and because of the well-known pharmacological properties of tetracycline (Tet) and analogs such as doxycycline. Here, we describe the adaptation of the Tet-inducible system for use in replication-incompetent HSV vectors. HSV vectors were constructed that contained several types of Tet-inducible promoters for foreign gene expression. These promoters contained a tetracycline response element (TRE) linked to either a minimal cytomegalovirus (CMV) immediate-early promoter, a minimal HSV ICP0 promoter, or a truncated HSV ICP0 promoter containing one copy of the HSV TAATGARAT cis-acting immediate-early regulatory element (where R represents a prime base). All three promoter constructs were regulated appropriately by doxycycline, as shown by the expression of the marker gene lacZ in cell lines engineered to express Tet transactivators. The ICP0 promoter constructs expressed the highest and most sustained levels of lacZ, but the CMV promoter construct had the highest relative level of induction, suggesting their use in different applications. To extend the utility of Tet-regulated HSV vectors, vectors were constructed that coexpressed an inducible Tet transactivator in addition to the inducible lacZ marker gene. This modification resulted in tetracycline-inducible gene expression that was not restricted to specific cell lines, and this vector was capable of inducible expression in irreversibly differentiated NT2 cells (NT-neurons) for several days. Finally, HSV vectors were constructed that expressed modified Tet transactivators, resulting in improved induction properties and indicating the flexibility of the Tet-regulated system for regulation of foreign gene expression in HSV vector-infected cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12542843     DOI: 10.1089/104303402320987815

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  9 in total

Review 1.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 2.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

Review 3.  The alpha-herpesviruses: molecular pathfinders in nervous system circuits.

Authors:  Mats I Ekstrand; L W Enquist; Lisa E Pomeranz
Journal:  Trends Mol Med       Date:  2008-02-14       Impact factor: 11.951

4.  Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system.

Authors:  Qingshen Gao; Mei Sun; Xiaodan Wang; Guo-Rong Zhang; Alfred I Geller
Journal:  Brain Res       Date:  2006-03-20       Impact factor: 3.252

5.  Cell- and region-specific miR30-based gene knock-down with temporal control in the rat brain.

Authors:  Beihui Liu; Haibo Xu; Julian F R Paton; Sergey Kasparov
Journal:  BMC Mol Biol       Date:  2010-12-06       Impact factor: 2.946

6.  Tetracycline regulated systems in functional oncogenomics.

Authors:  Arkadiusz Welman; Jane Barraclough; Caroline Dive
Journal:  Transl Oncogenomics       Date:  2007-03-28

Review 7.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13

8.  Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer.

Authors:  Senthilkumar Kalimuthu; Ji Min Oh; Prakash Gangadaran; Liya Zhu; Ho Won Lee; Yong Hyun Jeon; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

9.  Mechanistic effect of the human GJB6 gene and its mutations in HaCaT cell proliferation and apoptosis.

Authors:  Yuting Lu; Ruili Zhang; Zhenying Wang; Shuhua Zhou; Yali Song; Lamei Chen; Nan Chen; Wenmin Liu; Canan Ji; Wangli Wu; Li Zhang
Journal:  Braz J Med Biol Res       Date:  2018-07-23       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.